The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Advanced Materials Regulatory News (MGAM)

Share Price Information for Morgan Advanced Materials (MGAM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 314.50
Bid: 316.00
Ask: 317.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.316%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 314.50
MGAM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Annual Financial Report

2 Apr 2014 17:03

RNS Number : 9062D
Morgan Advanced Materials PLC
02 April 2014
 



Morgan Advanced Materials plc

 

2013 Annual Report

 

The following documents have today been posted or otherwise made available to shareholders:

 

a. Annual Report and Financial Statements for the year ended 31 December 2013 (2013 Annual Report);

b. Notice of the 2014 Annual General Meeting; and

c. Form of Proxy for the 2014 Annual General Meeting.

 

In accordance with Listing Rule 9.6.1, a copy of each of these documents has been uploaded to the National Storage Mechanism and will be available for viewing shortly at www.hemscott.com/nsm.do.

 

The documents are also available on the Company's website at www.morganadvancedmaterials.com in the 'Investors' section.

 

The Company's preliminary results announcement of 13 February 2014 contained a management report as well as audited financial statements which were prepared in accordance with the applicable accounting standards. The financial information set out in the Company's preliminary results announcement of 13 February 2014 does not constitute the Company's statutory accounts for the year ended 31 December 2013. Statutory accounts for 2013 are included in the 2013 Annual Report, which will be delivered to the registrar of companies following the Company's 2014 Annual General Meeting. The auditors have reported on those accounts; their report was (i) unqualified, (ii) did not include a reference to any matters to which the auditors drew attention by way of emphasis without qualifying their report and (iii) did not contain a statement under section 498(2) or (3) of the Companies Act 2006 in respect of the accounts for 2013.

 

The information below, which is extracted from the 2013 Annual Report, is included solely for the purpose of complying with DTR 6.3.5. This information should be read in conjunction with the Company's preliminary results announcement issued on 13 February 2014 (available at www.morganadvancedmaterials.com). This announcement is not a substitute for reading the full 2013 Annual Report. All page numbers and cross-references in the extracted information below refer to page numbers in the 2013 Annual Report. There are no related party transactions requiring disclosure.

 

Principal Risks and Uncertainties

 

The Group has an established risk management methodology in place which seeks to identify, quantify, manage and mitigate both existing and emerging risks, together with a comprehensive internal control framework and appropriate assurance processes. The Board considers that this is fundamental to achieving the Group aim of creating long-term sustainable shareholder value.

 

Risks are identified 'top down' by the Board and 'site up' though the Group's businesses and are quantified by assessing their inherent impact and mitigated probability to ensure that the true potential impact of any risk and its likelihood of materialising is appreciated throughout the Group. The day-to-day management of risk sits within the Group's internal control framework at the level of the Group where the impact would materialise, with the effectiveness of the controls and mitigating actions being monitored and assessed through a Group-wide review process. Senior members of the management team are responsible for the strategic management of the respective key risks, including related policy, guidelines and process.

 

During 2013, the Board/Audit Committee reviewed all risks with an inherent potential EBITA impact of above £5 million and the controls and assurance processes that are in place to mitigate those risks. As a result of this review, a number of actions were identified to improve controls and the mitigation of risk. For example, the review of both the 'top down' and 'site up' single point exposures identified the need to qualify alternate suppliers of key materials both internally and externally at certain of our businesses. The Board/Audit Committee annual review of key risks will continue into 2014 and beyond.

 

The following risks feature in the Group's key risk register and are those that the Board feels could have the most serious effect on achieving our strategy of building a sustainable business for the long term and delivering strong returns to our stakeholders.

 

 

RISK

MITIGATION

Strategy and strategic planning risks

Technology obsolescence

One of the Group's strategic priorities is that it aims to 'be innovative, differentiated and high value-added'. This is fundamental to achieving the goal of continuing to be one of the world's very best advanced materials companies.

 

Unforeseen/unmitigated technology obsolescence, the loss of control of proprietary technology or the loss of intellectual property/know-how would impact the Group's business and its ability to deliver on its strategic goal.

 

 

The Group has a Chief Technical Officer and a dedicated technology team which monitors technology and business developments. Specifically, the team has developed technology roadmaps for its major technology families to ensure it is at the leading edge of technology development, but also to understand emerging and competing technologies.

 

The technology team proactively manages the Group's technology pipeline and R&D investment in new/improving technologies. This technology pipeline is regularly reviewed by the Group Executive and the Board.

 

Where Group products are designed for a specific customer, they are developed in tandem with the customer to maintain leading-edge differentiated solutions of value.

 

The Group seeks to secure IP protection, where appropriate, for its existing and emerging portfolio of products; external advisers manage this protection globally.

 

Recruiting, maintaining and motivating high-quality staff

Another of the Group's strategic priorities is to 'find, keep and develop the right people'.

 

The advanced technological nature of the Group requires people with highly differentiated skillsets. Any inability to recruit, retain and develop the right people would impact the Group achieving its strategic priority.

 

 

 

Making Morgan a safe, fulfilling and rewarding Group to work for is the primary means of control and the Group has an HR Director and a network of HR professionals within the business along with policies and processes to manage the risks relating to its people. These cover areas including reward and recognition, health and safety, talent management, skills assessment and development, performance management and employee consultation.

 

A global employee survey was carried out in 2013, the results of which will inform further actions going forward.

 

In 2012 the Group launched a Graduate Leadership Programme and this ran for a successive year in 2013, with enhanced numbers of graduates and with a greater global focus.

 

Operational risks

Treasury risks

The Group's global nature means that it is exposed to uncertainties in the financial markets and the banking sector which heighten the Group's foreign exchange, interest rate, credit and liquidity risks as well as the risk of bank failure impacting the Group's cash.

 

 

The Group's Treasury function, Treasury Policy and guidelines provide strict controls on the selection of banks and cash management. The Treasury team proactively manages and is ultimately responsible for all of the Group's funding, liquidity, cash management, interest rate risk, foreign exchange risk and other treasury business.

 

Quality of contracts

As a global advanced materials business supplying into critical applications, our quality of contracts must match our quality of products. Ineffective contract risk management could result in significant liabilities for the Group and damage customer relationships.

 

The Group has an in-house legal function supplemented by external lawyers.

 

The Group legal policy requires in-house legal review of high-value or high-risk contracts to ensure that the contracts contain the appropriate protection for the Group. CEO approval is required before any part of the business can enter into an unlimited liability contract or one where the liabilities could exceed £5 million. In 2013, the CEO approved entry into only two contracts with this liability profile, where the underlying risks were considered to be within the Group's risk appetite.

 

To the extent that risk has not been managed out of the contractual process, the Group has insurance cover approved by the Board, including product liability insurance.

IT risks and cyber risks

In order to meet the Group's strategic objectives the viability of its underlying IT infrastructure is essential. If a critical business system was to fail or the Group lost critical data or information through inadequate data management or security of IT systems, the business would be impacted.

 

 

 

The Group has an IT policy and guidelines in place as well as Group and business IT teams to manage the Group's infrastructure technology roadmap and IT risks.

 

During the course of 2013 there has been focus on testing the global infrastructure, including elements of IT auditing into the internal audit process, reviewing data management and reviewing/developing the Group's business continuity plans in relation to IT risk.

 

In relation to cyber risk a number of steps have been taken in 2013, security guidance documents have been introduced, access privileges have been improved, and network monitoring enhanced. Further improvements are planned in 2014.

 

Product quality, safety and liability

Products used in applications for which they were not intended or inadequate quality control systems/overcommitting on specifications could result in products not meeting specifications, which could lead to significant liabilities and reputational damage.

 

Many of the Group's products are designed to customer specifications. Over 90% of the Group's manufacturing output is accredited to ISO 9001 and the Group's quality management systems and training help ensure that Morgan's products meet or exceed customer requirements and national/international standards.

 

Contracts relating to products used in potential high-risk applications are subject to mandatory legal review.

 

There were no material product quality issues in 2013.

 

The Group insurance programme includes product liability insurance, this Group-level insurance is reviewed annually by the Board.

 

Single point exposures

The Group has a number of potential single point exposure risks, these include:

Ø Single point supplier - a significant interruption of a key internal or external supply could impact business continuity.

Ø Single point customer - the unmitigated loss of a major customer could have an impact on Group profit.

Ø Single point profit - a key site exposed to a strike, a natural catastrophe or serious incident such as fire could impact business continuity.

 

 

The Group Executive is responsible for monitoring and managing these single point exposures.

 

Local and Regional management of these risks involves monitoring and reviewing supply chains (internal and external), dual/multiple sourcing of materials or strategic stock, fire protection systems, creating and testing disaster recovery plans, and maintaining product quality and customer relationships.

 

The Group insurance programme includes business interruption cover, this Group-level insurance is reviewed annually by the Board.

 

Environment, health and safety (EHS) risks

The Group operates a number of manufacturing facilities around the globe. A failure in the Group's EHS procedures could lead to environmental damage or lead to injury or death of individuals, with a consequential impact on operations and raising the risk of regulatory action being taken against the Group. Any such action could result in litigation, resultant damages and damage to reputation.

 

 

The Group has a well-developed EHS programme managed by the EHS Director, with site-based EHS officers to implement and monitor EHS adherence at site level.

 

During 2013 the Group has implemented a number of safety performance improvement programmes and launched a process to analyse and understand the root causes and consequences of all lost time accidents. In 2014 a global behavioural safety programme will be introduced Group-wide.

 

Compliance and ethics risks

Changes to or non-compliance with laws and regulation

The Group's global operations must comply with a range of national and international laws and regulations including those related to bribery and corruption, human rights, exports and competition/anti-trust.

 

A failure to comply with any applicable laws/regulations could result in civil or criminal liabilities, individual or corporate fines and could also result in debarment from government related contracts and reputational damage.

The Group is committed to the highest standards of corporate and individual behaviour and this commitment is set out in the Group's Core Values Statement and Ethics Policy.

 

Due to the potential magnitude of corporate fines, compliance risks are identified as some of the most significant risks for a number of reasons:

Ø Morgan's historic breach of anti-trust laws creates a greater sensitivity to anti-trust risk and means that the Group could be subject to the greater potential liabilities which attach to repeat offenders.

Ø The location of a number of Morgan businesses and customers means they are exposed to greater bribery risk.

Ø Morgan exports from the US and is therefore subject to the stringent US export laws.

 

The Group's Responsible Business Programme, and the US Export Director, address these areas of risk through policies, training/education and reporting/assurance processes.

External risks

Changing political, economic and social environment

The Group operates in a range of markets and geographies around the world and can be affected by political, economic, social or regulatory developments or instability such as the Euro crisis and US government debt/'fiscal cliff'. Some of those risks related to Morgan in 2013 include Venezuelan regime change, Argentinian economic policies, tensions between China, Taiwan and Japan, and US fiscal cliff.

 

The Group's broad market/geographic spread helps to mitigate the effects of political and economic crises.

 

Key risks and events are regularly tracked at a business and Group level, with contingency plans in place to manage the changing situations.

 

Financial and treasury controls limit exposure to foreign currency, interest rate, credit and liquidity risk. Also, the Group maintains a carefully managed debt facility to ensure that its debt ratio is within acceptable market tolerances.

 

Pension funding

The Group participates in defined pension arrangements which are exposed to fluctuating interest rates, investment values and inflation. This coupled with the increased longevity of members could result in funding burdens on the Group in the future.

Active management of the pension scheme assets is the primary means of mitigation. This comprises management both internally within the Group but also externally through corporate actuaries and professional advisers.

 

 

 

Directors' Responsibility Statement

 

The 2013 Annual Report contains the following statements regarding responsibility for the financial statements in compliance with DTR 4.1.12. Responsibility is for the full Annual Report and Financial Statements 2013 and not the condensed statements required to be set out in the Annual Financial Report announcement.

 

Each of the Directors, the names and roles of whom are set out on pages 46 and 47 of the 2013 Annual Report, confirms to the best of their knowledge: 

 

· The Group's Financial statements, which have been prepared in accordance with IFRS as adopted by the EU, give a true and fair view of the assets, liabilities, financial position and profit of the Group; and

· The management report (comprising the Directors' report and the Strategic report) includes a fair review of the development and performance of the business and the position of the Group, together with a description of the principal risks and uncertainties that it faces.

 

Enquiries: Stephanie Mackie, Deputy Company Secretary

Telephone: 01753 837000

 

2 April 2014

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACSUURNRSAASRAR
Date   Source Headline
1st May 20245:38 pmRNSHolding(s) in Company
24th Apr 20247:00 amRNSCapital Markets Update
5th Apr 202412:55 pmRNSAnnual Financial Report
4th Apr 20241:16 pmRNSDirector/PDMR Shareholding
27th Mar 20244:52 pmRNSDirector/PDMR Shareholding
27th Mar 20244:50 pmRNSDirector/PDMR Shareholding
27th Mar 20244:49 pmRNSDirector/PDMR Shareholding
27th Mar 20244:48 pmRNSDirector/PDMR Shareholding
14th Mar 20249:42 amRNSDirector/PDMR Shareholding
14th Mar 20249:41 amRNSDirector/PDMR Shareholding
13th Mar 202412:10 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSMorgan Advanced Materials Full Year 2023 Results
27th Dec 20237:00 amRNSDirector/PDMR Shareholding
19th Dec 20231:56 pmRNSDirector/PDMR Shareholding
18th Dec 20234:25 pmRNSBlock listing Interim Review
22nd Nov 202310:07 amRNSDirector/PDMR Shareholding
9th Nov 20237:00 amRNSQ3 Trading Update
9th Oct 20234:43 pmRNSDirector/PDMR Shareholding
26th Sep 202312:24 pmRNSDirector/PDMR Shareholding
16th Aug 202311:27 amRNSDirector/PDMR Shareholding
7th Aug 20235:24 pmRNSDirector/PDMR Shareholding
4th Aug 20237:00 amRNSHalf-Year Results for Period Ended 30 June 2023
13th Jul 20234:49 pmRNSDirector/PDMR Shareholding
5th Jul 20234:51 pmRNSDirector/PDMR Shareholding
29th Jun 20235:06 pmRNSResult of AGM
29th Jun 20237:00 amRNSH1 Trading Update
22nd Jun 202311:50 amRNSBlock listing Interim Review
31st May 20233:52 pmRNSDirector/PDMR Shareholding
26th May 20233:28 pmRNSNotice of Annual General Meeting 2023
24th May 20233:59 pmRNSDirector/PDMR Shareholding
11th May 202312:06 pmRNSDirector/PDMR Shareholding
11th May 202312:01 pmRNSDirector/PDMR Shareholding
11th May 202311:59 amRNSDirector/PDMR Shareholding
9th May 20235:59 pmRNSDirector/PDMR Shareholding
4th May 20235:28 pmRNSAnnual Report & Accounts 2022
3rd May 20235:38 pmRNSDirector/PDMR Shareholding
3rd May 20235:28 pmRNSDirector/PDMR Shareholding
28th Apr 20235:45 pmRNSInformation required by DTR 4.1
28th Apr 20237:00 amRNSFull-year results for the period ended 31 Dec 2022
13th Apr 20237:00 amRNSNotification of Full-Year Results
7th Feb 20237:00 amRNSUpdate on Trading and Cyber Security Incident
18th Jan 20237:00 amRNSAppointment of Chair Designate
10th Jan 20237:00 amRNSNotice of Cyber Security Incident
22nd Dec 202211:01 amRNSBlock listing Interim Review
16th Dec 20224:44 pmRNSHolding(s) in Company
6th Dec 20227:00 amRNSAccelerated Pension Contribution
6th Dec 20227:00 amRNSCapital Markets Event
23rd Nov 202210:01 amRNSDirector/PDMR Shareholding
15th Nov 20225:06 pmRNSDirector/PDMR Shareholding
10th Nov 20228:03 amRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.